Page 842 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat

798 INDEX INDEX

Tachycardia (continued) Tearing stimulation, 240 Terminal deoxynucleotidyl transferase Theophylline, 687
metronidazole, 195 Teenagers (TdT), 104 therapeutic index of, 234
with myocarditis, 313 common causes of death, 272 Tertiary adrenal insufficiency, 349 Therapeutic antibodies, 121, 122
PCP, 571 Teeth Tertiary disease prevention, 270 Therapeutic index (TI), 234
phenoxybenzamine, 244 congenital syphilis, 147 Tertiary hyperparathyroidism, 345 Therapeutic window, 234
reflex, 244 dentinogenesis imperfecta, 51 Tesamorelin, 328 Thermogenin, 78
stimulants and, 570 discoloration, 192, 204, 250, 614 Testes Theta rhythm (EEG), 497
supraventricular, 245 Gardner syndrome, 387 descent of, 624 Thiamine, 66
thyroid hormones, 354 osteogenesis imperfecta, 51 lymphatic drainage of, 624 Thiazide diuretics, 609
Wolff-Parkinson-White syndrome, Sjögren syndrome and, 468 progesterone production, 630 in gout, 250
294 Telangiectasias Testicular atrophy in heart failure, 309
Tachyphylaxis, 235 basal cell carcinomas, 484 alcoholism, 571 in hypertension, 316
Tacrolimus hereditary hemorrhagic, 316 muscular dystrophy, 61 Thiazides, 609
hyperglycemia, 249 Telencephalon, 490 Testicular cancer, 439, 442, 653 Thionamides, 354
immunosuppression, 120 Tellurite agar, 126 Testicular torsion, 651 Thiopental, 546, 550
Tactile hallucinations, 559 Telomerase Testicular tumors Thioridazine, 573
cocaine, 571 action of, 38 germ cell, 652–653 Third-degree (complete) AV block,
Taenia solium, 160, 161 Telophase, 46 non-germ cell tumors, 653 295
Takayasu arteritis, 314 Temazepam, 546 Testing agencies, 24 3rd pharyngeal pouch, 621
Tamm–Horsfall mucoprotein, 594 Temperature receptors, 494 Testis-determining factor, 622 3rd pharyngeal arch, 620
Tamoxifen, 443, 656 Temperature regulation, 498 Testosterone, 636, 658 Thirst
hot flashes with, 249 Temperature sensation androgen insensitivity syndrome, hypothalamus and, 498
Tamsulosin, 244, 658 cape-like distribution loss, 492, 530 639 30S inhibitors, 191
Tanner stages (sexual development), loss with strokes, 514 Leydig cell secretion, 628 Thoracic aortic aneurysm, 300, 302
637 Temporal arteritis, 314 Sertoli cells, 628 Thoracic outlet syndrome, 448, 684
Tardive dyskinesia Temporalis muscle, 507 SHBG effect on, 337 Threadworms, 159
antipsychotic drugs and, 573 Temporal lobe, 501, 514 signaling pathways for, 337 Threonine, 81
metoclopramide adverse effect, Temporal lobe encephalitis, 164 spermatogenesis, 628 Threonine kinase, 224
400 Tendinopathy (rotator cuff), 446 Testosterone-secreting tumors, 639 Thrombi
nigrostriatal pathway, 499 Tendinous xanthomas, 301 Testosterone synthesis, 199 atherosclerosis, 302
Target cells, 415 familial hypercholesterolemia, 94 Test-taking strategy, 22–23 mural, 305, 307
postsplenectomy, 98 Tendonitis Tetanospasmin, 132 post-MI, 305
Tarsal tunnel syndrome, 453 drug reaction and, 250 blocks release of GABA, 138 Thrombin, 436
Taste fluoroquinolones, 195 Tetanus Thromboangiitis obliterans, 314
cranial nerve lesions and, 532 Tendons exotoxins, 131 Thrombocytes (platelets), 407
loss with stroke, 514 collagen in, 50 Tetanus toxin, 110 disorders, 426–427
thalamic relay for, 498 Tenecteplase (TNK-tPA), 437 Tetany function tests of, 426
TATA box, 41 Teniposide, 442 hypocalcemia, 591 heparin adverse effects, 436
Taxanes, 441 Tennis elbow, 459 hypoparathyroidism, 344 leukemias, 432
Tay-Sachs disease “Tennis rackets” (Birbeck) granules, Tetrabenazine liver markers, 390
lysosomal storage disease, 88 Huntington disease, 549 mixed coagulation disorders, 428
Tazobactam, 189 434 Tourette syndrome, 572 thrombolytics and, 437
TCA cycle, 77 Tenofovir, 203 Tetracaine, 550 transfusion of, 421, 429
hyperammonemia, 82 Tenosynovitis, 468 Tetracyclines, 192 in wound healing, 216
metabolic site, 72 Tension headaches, 518 esophagitis, 249 Thrombocythemia (essential), 433
pyruvate metabolism, 77 Tension pneumothorax, 680, 682 Fanconi syndrome, 251 Thrombocytopenia, 407
rate-determining enzyme for, 73 Tensor fascia latae muscle, 453 photosensitivity, 250 Class IA antiarrhythmics, 322
TCA toxicity Tensor tympani muscle, 620 protein synthesis inhibition, 191 cytarabine, 440
treatment of, 233 Tensor veli palatini muscle, 620 pseudotumor cerebri and, 521 drug reaction and, 250
T cells, 127, 409 Teratogens teratogenicity, 204, 614 Escherichia coli, 145
activation, 103 ACE inhibitors, 610 tooth discoloration, 250 ganciclovir, 202
adaptive immunity, 99 aminoglycosides, 191 Tetrahydrobiopterin (bh4) glycoprotein IIb/IIIa inhibitors, 438
anergy, 110 angiotensin II receptor blockers, in phenylketonuria, 84 heparin adverse effects, 436
cell surface proteins, 110 610 Tetrahydrofolic acid (THF), 68, oxazolidinones, 193
corticosteroid effects, 120 in fetal development, 612 194 protease inhibitors, 203
cytokine production, 101, 108 fetal effects of, 614 Tetralogy of Fallot, 298 recombinant cytokines, 121
cytotoxic, 102 griseofulvin, 200, 204 22q11 syndromes, 300 sulfa drug allergies, 252
delayed (type IV) hypersensitivity, leflunomide, 486 fetal alcohol syndrome, 300 TORCH infections, 182
101 lithium as, 574 outflow tract formation, 281 transfusion for, 429
differentiation and maturation, methimazole as, 354 Tetrodotoxin, 247 Wiskott-Aldrich syndrome, 117
98, 102 propylthiouracil in pregnancy, 354 TGF-β Thrombocytosis
disorders of, 116, 117 ribavirin, 204 in wound healing, 216 postsplenectomy, 98
functions, 101 vitamin A, 66 neural development, 490 Thromboembolic event
leflunomide effects, 486 warfarin as, 436 regulatory T cells, 102 atrial fibrillation, 295
lymph nodes, 96 Teratoma Thalamus Thrombogenesis, 411
macrophage interaction, 102 immature, 647 development of, 490 Thrombolytic drugs, 413, 437
major functions of, 101 mature cystic, 647 limbic system and, 498 Thrombophlebitis
neoplasms, 430 testicular, 653 neuropathic pain, 515 pancreatic cancer, 398
polysaccharide antigens and, 127 Terazosin, 244 Thalassemia, 418 Thrombopoietin, 121
regulatory, 102 Terbinafine, 199 target cells in, 415 signaling pathways, 337
sirolimus effect, 120 Terbutaline, 242 Thalidomide Thrombosis
spleen, 98 Teres minor, 446 teratogenicity, 614 celecoxib, 486
thymus, 98 Teriparatide, 462, 487 Thayer-Martin agar, 126 contraceptive and hormone
untreated HIV, 176 Terminal bronchioles, 660 Theca-lutein cysts, 642, 646 replacement, 250
Tea-colored urine, 425 Terminal complement deficiencies Thecoma, 647 essential thrombocythemia, 433
“Teardrop” RBCs, 414, 433 (C5–C9), 107 Thenar muscles, 447, 448, 450 homocystinuria, 84

FAS1_2019_21_Index_749-806.indd 798 11/21/19 12:27 PM